Ichthyosis in Sjögren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion

Archives of Dermatological Research

Volumn 302, Issue 6, 2010, Pages 443-451

  Rizzo, William B ^a   S'Aulis, Dana ^a   Jennings, M Anitia ^a   Crumrine, Debra A ^b   Williams, Mary L ^b   Elias, Peter M ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aldehyde dehydrogenase; Fatty alcohol; Fatty aldehyde; Genetic disease; Ichthyosis; Stratum corneum

Indexed keywords

ALDEHYDE;

ADOLESCENT; ADULT; ARTICLE; BODY FLUID; CELL SECRETION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEOCYTE; CYTOPLASM; ENZYME DEFICIENCY; EPIDERMIS; EPIDERMIS GRANULAR LAYER; EXTRACELLULAR MATRIX; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LAMELLAR BODY; LAMELLAR ICHTHYOSIS; MALE; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; SJOEGREN LARSSON SYNDROME; SKIN CELL; SKIN PERMEABILITY; SKIN STRUCTURE; STRATUM CORNEUM;

ADOLESCENT; ADULT; ALDEHYDE OXIDOREDUCTASES; CELL MEMBRANE PERMEABILITY; CELL SURFACE EXTENSIONS; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; EPIDERMIS; FEMALE; FIBROBLASTS; HUMANS; ICHTHYOSIS, LAMELLAR; INFANT; MALE; MUTATION; OXIDATION-REDUCTION; SECRETORY PATHWAY; SJOGREN-LARSSON SYNDROME;

EID: 77955551313     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-009-1022-y     Document Type: Article

References (40)

1. AR Brash Z Yu WE Boeglin C Schneider 2007 The hepoxilin connection in the epidermis FEBS J 274 3494 3502 10.1111/j.1742-4658.2007.05909.x 1:CAS:528:DC%2BD2sXosVOit70%3D 17608720 (Pubitemid 47052414)
2. V De Laurenzi GR Rogers DJ Hamrock LN Marekov PM Steinert JG Compton N Markova WB Rizzo 1996 Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene Nat Genet 12 52 57 10.1038/ng0196-52 8528251 (Pubitemid 26011319)
3. M Demerjian DA Crumrine LM Milstone ML Williams PM Elias 2006 Barrier dysfunction and pathogenesis of neutral lipid storage disease with ichthyosis (Chanarin-Dorfman syndrome) J Invest Dermatol 126 2032 2038 10.1038/sj.jid. 5700332 1:CAS:528:DC%2BD28XotFCjtbo%3D 16741516
4. PM Elias 1983 Epidermal lipids, barrier function, and desquamation J Invest Dermatol 80 Suppl 44s 49s 10.1038/jid.1983.12 1:STN:280: DC%2BC3czkt12jsA%3D%3D
5. PM Elias C Cullander T Maura U Rassner L Kömüves BE Brown GK Menon 1998 The secretory granular cell: the outermost granular cell as a specialized secretory cell J Invest Dermatol Symp Proc 3 87 100 1:STN:280:DyaK1cvgtlyruw%3D%3D
6. PM Elias GK Menon 1991 Structural and lipid biochemical correlates of the epidermal permeability barrier Adv Lipid Res 24 1 26 1:CAS:528: DyaK38Xitlansb4%3D 1763710
7. PM Elias ML Williams WM Holleran YJ Jiang M Schmuth 2008 Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism J Lipid Res 49 697 714 10.1194/jlr.R800002-JLR200 1:CAS:528:DC%2BD1cXjvFegs7o%3D 18245815
8. KR Feingold MQ Man E Proksch GK Menon BE Brown PM Elias 1991 The lovastatin-treated rodent: a new model of barrier disruption and epidermal hyperplasia J Invest Dermatol 96 201 209 10.1111/1523-1747.ep12461153 1:CAS:528:DyaK3MXit1Kqt7o%3D 1991980
9. K Hanley LG Kömüves DC Ng K Schoonjans SS He P Lau DD Bikle ML Williams PM Elias J Auwerx KR Feingold 2000 Farnesol stimulates differentiation in epidermal keratinocytes via PPARalpha J Biol Chem 275 11484 11491 10.1074/jbc.275.15.11484 1:CAS:528:DC%2BD3cXislSgsrs%3D 10753967 (Pubitemid 30212804)
10. DD Hinson KL Chambliss MJ Toth RD Tanaka KM Gibson 1997 Post-translational regulation of mevalonate kinase by intermediates of the cholesterol and nonsterol isoprene biosynthetic pathways J Lipid Res 38 2216 2223 1:CAS:528:DyaK2sXnsFGkt7g%3D 9392419
11. M Ito K Oguro Y Sato 1991 Ultrastructural study of the skin in Sjögren-Larsson syndrome Arch Dermatol Res 283 141 148 10.1007/BF00372053 1:STN:280:DyaK3MzivVGnsQ%3D%3D 1867477
12. S Jagell J Heijbel 1982 Sjögren-Larsson syndrome: physical and neurological features. A survey of 35 patients Helv Paediatr Acta 37 519 530 1:STN:280:DyaL3s7mtVeltA%3D%3D 7166487
13. S Jagell S Lidén 1982 Ichthyosis in the Sjögren-Larsson syndrome Clin Genet 21 243 252 1:STN:280:DyaL383lvF2mtg%3D%3D 6179662
14. PF James RA Zoeller 1997 Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sjögren-Larsson syndrome J Biol Chem 272 23532 23539 10.1074/jbc.272.38. 23532 1:CAS:528:DyaK2sXmtlOmtLg%3D 9295289 (Pubitemid 27410921)
15. F Jobard C Lefevre A Karaduman C Blanchet-Bardon S Emre J Weissenbach M Ozgüc M Lathrop JF Prud'homme J Fischer 2002 Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1 Hum Mol Genet 11 107 113 10.1093/hmg/11.1.107 1:CAS:528:DC%2BD38XpsFCktQ%3D%3D 11773004
16. MR Judge BD Lake VV Smith GT Besley JI Harper 1990 Depletion of alcohol (hexanol) dehydrogenase activity in the epidermis and jejunal mucosa in Sjögren-Larsson syndrome J Invest Dermatol 95 632 634 10.1111/1523-1747. ep12514294 1:CAS:528:DyaK3MXitVCqsbk%3D 2250105
17. TL Kelson M Secor Jr WB Rizzo 1997 Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization Biochim Biophys Acta 1335 99 110 1:CAS:528:DyaK2sXhvFWiu7Y%3D 9133646
18. C Lefevre B Bouadjar V Ferrand G Tadini A Megarbane M Lathrop JF Prud'homme J Fischer, et al. 2006 Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3 Hum Mol Genet 15 767 776 10.1093/hmg/ddi491 1:CAS:528:DC%2BD28XhsF2mtbc%3D 16436457 (Pubitemid 43264701)
19. C Lefevre B Bouadjar A Karaduman F Jobard S Saker M Ozguc M Lathrop JF Prud'homme J Fischer 2004 Mutations in ichthyin a new gene on chromosome 5q33 in a new form of autosomal recessive congenital ichthyosis Hum Mol Genet 13 2473 2482 10.1093/hmg/ddh263 1:CAS:528:DC%2BD2cXnvVOktb8%3D 15317751 (Pubitemid 39377851)
20. D Levisohn B Dintiman WB Rizzo 1991 Sjögren-Larsson syndrome. Case reports Pediatr Dermatol 8 217 220 10.1111/j.1525-1470.1991.tb00863.x 1:STN:280:DyaK38%2FotVCntQ%3D%3D 1836061
21. S Liden S Jagell 1984 The Sjögren-Larsson syndrome Int J Dermatol 23 247 253 10.1111/j.1365-4362.1984.tb01240.x 1:STN:280:DyaL2c3jvVGltw%3D%3D 6735549
22. KC Madison 2003 Barrier function of the skin: "la raison d'etre" of the epidermis J Invest Dermatol 121 231 241 10.1046/j.1523-1747. 2003.12359.x 1:CAS:528:DC%2BD3sXmsVansrg%3D 12880413 (Pubitemid 36969895)
23. LY Matsuoka BG Kousseff K Hashimoto 1982 Studies of the skin in Sjögren-Larsson syndrome by electron microscopy Am J Dermatopathol 4 295 301 10.1097/00000372-198208000-00002 1:STN:280:DyaL3s%2Fnt1CgtA%3D%3D 7149178
24. TE Meigs DS Roseman RD Simoni 1996 Regulation of 3-hydroxy-3- methylglutaryl-coenzyme A reductase degradation by the nonsterol mevalonate metabolite farnesol in vivo J Biol Chem 271 7916 7922 10.1074/jbc.271.14.7916 1:CAS:528:DyaK28XitFarsLg%3D 8626470 (Pubitemid 26108608)
25. GK Menon KR Feingold M Mao-Qiang M Schaude PM Elias 1992 Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis J Invest Dermatol 98 209 219 10.1111/1523-1747.ep12555880 1:CAS:528:DyaK38XhtVegtbw%3D 1732385
26. Rizzo WB (2001) Sjögren-Larsson syndrome: fatty aldehyde dehydrogenase deficiency. In: Scriver CR, Beckman K, Small GM, Valle D (eds) The metabolic & molecular bases of inherited disease, vol 2. McGraw-Hill, New York, pp 2239-2258
27. WB Rizzo 2007 Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency Mol Genet Metab 90 1 9 10.1016/j.ymgme.2006.08.006 1:CAS:528:DC%2BD28Xht12qtLzK 16996289 (Pubitemid 44856293)
28. WB Rizzo G Carney Z Lin 1999 The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene Am J Hum Genet 65 1547 1560 10.1086/302681 1:CAS:528:DC%2BD3cXjvFemsw%3D%3D 10577908 (Pubitemid 30468667)
29. WB Rizzo DA Craft 1991 Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol: NAD + oxidoreductase in cultured fibroblasts J Clin Invest 88 1643 1648 10.1172/JCI115478 1:CAS:528:DyaK38Xls1Kmtw%3D%3D 1939650
30. WB Rizzo DA Craft 2000 Sjögren-Larsson syndrome: accumulation of free fatty alcohols in cultured fibroblasts and plasma J Lipid Res 41 1077 1081 1:CAS:528:DC%2BD3cXltF2qtrs%3D 10884288
31. WB Rizzo DA Craft T Somer G Carney J Trafrova M Simon 2008 Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome J Lipid Res 49 410 419 10.1194/jlr.M700469-JLR200 1:CAS:528:DC%2BD1cXhsVaitbc%3D 17971613 (Pubitemid 351213626)
32. RJ Sanders R Ofman G Dacremont RJ Wanders S Kemp 2008 Characterization of the human omega-oxidation pathway for omega-hydroxy-very-long-chain fatty acids FASEB J 22 2064 2071 10.1096/fj.07-099150 1:CAS:528:DC%2BD1cXnsVensL0%3D 18182499 (Pubitemid 351811482)
33. M Schmuth G Yosipovitch ML Williams F Weber H Hintner S Ortiz-Urda K Rappersberger D Crumrine KR Feingold PM Elias 2001 Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis J Invest Dermatol 117 837 847 10.1046/j.0022-202x.2001.01471.x 1:CAS:528: DC%2BD3MXotFWjtro%3D 11676820 (Pubitemid 33001199)
34. A Shibaki M Akiyama H Shimizu 2004 Novel ALDH3A2 heterozygous mutations are associated with defective lamellar granule formation in a Japanese family of Sjögren-Larsson syndrome J Invest Dermatol 123 1197 1199 10.1111/j.0022-202X.2004.23505.x 15610535 (Pubitemid 39586847)
35. T Sjögren T Larsson 1957 Oligophrenia in combination with congenital ichthyosis and spastic disorders Acta Psychiatr Neurol Scand 32 Suppl 113 1 113
36. PHMF van Domburg MAAP Willemsen JJ Rotteveel JG de Jong HOM Thijssen A Heerschap JRM Cruysberg RJA Wanders FJM Gabreëls PM Steijlen 1999 Sjögren-Larsson syndrome: clinical and MRI/MRS findings in FALDH-deficient patients Neurology 52 1345 1352 10227616
37. MAAP Willemsen JRM Cruysberg JJ Rotteveel AL Aandekerk PHMF van Domburg AF Deutman 2000 Juvenile macular dystrophy associated with deficient activity of fatty aldehyde dehydrogenase in Sjögren-Larsson syndrome Am J Ophthalmol 130 782 789 10.1016/S0002-9394(00)00576-6 1:CAS:528:DC%2BD3cXovFKgt7Y%3D 11124298 (Pubitemid 32000860)
38. MAAP Willemsen MA Lutt PM Steijlen JR Cruysberg M van der Graaf MW Nijhuis-van der Sanden JW Pasman E Mayatepek JJ Rotteveel 2001 Clinical and biochemical effects of zileuton in patients with the Sjögren-Larsson syndrome Eur J Pediatr 160 711 717 1:CAS:528:DC%2BD3MXosFGgurg%3D 11795678
39. MAAP Willemsen JJ Rotteveel JG de Jong RJA Wanders L Ijlst GFM Hoffmann E Mayatepek 2001 Defective metabolism of leukotriene B4 in the Sjögren-Larsson syndrome J Neurol Sci 183 61 67 10.1016/S0022-510X(00) 00474-3 1:CAS:528:DC%2BD3MXpsFOjtQ%3D%3D 11166796 (Pubitemid 32141074)
40. MAAP Willemsen M van der Graaf MS van der Knaap A Heerschap PHMF van Domburg FJ Gabreels JJ Rotteveel 2004 MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy AJNR Am J Neuroradiol 25 649 657 15090362